Trial intelligence / Profile preview

Special Drug Use-Results Survey of Onoact in Tachyarrhythmia with Cardiac Dysfunction

jRCT1080222572Completed

Sponsor
Ono Pharmaceutical
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of pafuramidine in Atrial fibrillation (AFib), atrial flutter (AFL), tachyarrhythmia and 1 more, sponsored by Ono Pharmaceutical. Started Aug 2014; status: completed.

02

Drugs

pafuramidine
03

Conditions

Atrial fibrillation (AFib)atrial flutter (AFL)tachyarrhythmiaheart failure (HF)

Beyond the preview

Go deeper on jRCT1080222572.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080222572.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call